Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease
published in: Current Medical Research and Opinion
date of publication: 2007-04-01
main subject: Parkinson's disease
Cites articles
There is nothing here
Article - wd:Q94522127